Accessibility Menu
Silvergate Capital logo

Silvergate Capital(OTC) SI

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-93%
5 Year-99%
1 Year+70%
1 Month+89%
N/A
Silvergate Capital last closing stock price
MetricPriceDate
Last closeUSD 0.852026-09-04
Silvergate Capital stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+16.44%USD 0.732026-08-28
1 month+88.89%USD 0.452026-08-05
3 month+136.11%USD 0.362026-06-05
Year to date+183.33%USD 0.302025-12-31
1 year+70%USD 0.502025-09-04
3 year+346.66%USD 0.192023-09-05
5 year-99.3%USD 120.652021-09-03
Since inception-93.21%USD 12.522019-11-07

Silvergate Capital Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$60.06M

Net Income (TTM)

-$35.03M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Sep 8, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Silvergate Capital

Shoulder Innovations, Inc. is a medical device company specializing in innovative shoulder replacement systems. Founded in 2009 and headquartered in Grand Rapids, MI, the company aims to enhance patient outcomes through advanced technology and design.

Products and Services
  • Shoulder replacement systems designed for improved patient recovery
  • Innovative surgical instruments to support orthopedic procedures
  • Comprehensive training and support for healthcare professionals
Growth Outlook
  • Revenue increased to $17.2 million in Q2 2026, up from $16.7 million in Q1 2026
  • Gross profit margin improved to 78.3% in Q2 2026, indicating operational efficiency
  • Strong cash position with $24.5 million in cash and equivalents as of June 2026
Financial Highlights
  • Trailing twelve months (TTM) revenue of $66.5 million, reflecting steady growth
  • Current ratio of 10.71, indicating strong liquidity and financial health
  • Net income of -$10.2 million in Q2 2026, showing ongoing investment in growth
Shoulder Innovations, Inc. is positioned in the healthcare sector, focusing on orthopedic solutions. The company has demonstrated a commitment to innovation, as evidenced by its increasing revenue and improving gross profit margins. The strong cash position allows for continued investment in research and development, which is crucial for maintaining competitive advantage in the medical device industry. With a solid foundation and a clear growth trajectory, Shoulder Innovations, Inc. presents an intriguing opportunity for potential investors interested in the healthcare market.
AI Generated • Aug 21, 2026

Industry

Banks

Employees

279

CEO

Alan J. Lane

Headquarters

Grand Rapids, MI 49507, US

SI Financials

Key Financial Metrics (TTM)

Gross Margin

77.34%

Operating Margin

-58.53%

Net Income Margin

-58.33%

Return on Equity

-25.67%

Return on Capital

-16.88%

Return on Assets

-23.05%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$46.45M

Operating Income

-$35.15M

EBITDA

-$33.03M

Operating Cash Flow

-$37.09M

Capital Expenditure

-$9.99M

Free Cash Flow

-$47.08M

Cash & ST Invst.

$98.99M

Total Debt

$14.85M

Silvergate Capital Performance Analysis

Silvergate Capital annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 175,650,000N/A
20222022-12-31USD -524,137,000N/A
Silvergate Capital sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-306.7%
Q42025-12-3122.6%
Q12026-03-3115.9%
Q22026-06-302.8%
Silvergate Capital annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD 2.91N/A
20222022-12-31USD -30.07N/A
Silvergate Capital sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3054.7%
Q42025-12-3111.6%
Q12026-03-31-7.9%
Q22026-06-30-19.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$17.18M

+56.0%

Gross Profit

$13.44M

+75.1%

Gross Margin

78.26%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

74

N/A

Net Income

-$10.15M

+47.1%

EBITDA

-$10.15M

+44.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$98.99M

+149.8%

Total Debt

$14.85M

-0.1%

Accounts Receivable

$10.87M

+57.9%

Inventory

$22.92M

+34.2%

Long Term Debt

$14.81M

+0.2%

Short Term Debt

$37.00K

-54.9%

Return on Assets

-23.05%

N/A

Return on Invested Capital

-25.26%

N/A

Free Cash Flow

-$9.55M

-52.4%

Operating Cash Flow

-$7.39M

-54.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
INGNInogen, Inc.
$5.42-0.55%
SNWVSANUWAVE Health Inc.
$4.38-1.57%
MDXHMDxHealth S.A.
$0.75+3.06%
OMOutset Medical, Inc.
$3.59+0.70%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.15-0.12%
NVDANvidia
$230.36+0.01%
PATHUiPath
$15.19-0.17%
INTCIntel
$95.80+0.05%

Questions About SI

What is the current price of Silvergate Capital?

Silvergate Capital is trading at N/A per share.

What is the 52-week range for Silvergate Capital?

Over the past 52 weeks, Silvergate Capital has traded between N/A and N/A.

How much debt does Silvergate Capital have?

As of the most recent reporting period, Silvergate Capital reported total debt of $4.32B.

How much cash does Silvergate Capital have on hand?

Silvergate Capital does not have cash on hand data available.

What is Silvergate Capital’s dividend yield?

Silvergate Capital does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.